NexPoint shareholders approve 2026 LTIP, reject liquidation proposal at annual meeting

NEXPOINT DIVERSIFIED REAL ESTATE TRUST

Shareholders approved the 2026 Long Term Incentive Plan (26,945,964 for, 2,833,644 against).
Shareholder proposal to liquidate assets defeated decisively (4,570,997 for, 25,160,407 against).
All seven trustee nominees elected, including James Dondero, Arthur Laffer, Catherine Wood.
Advisory say-on-pay approved (26,993,180 for, 2,516,601 against).
Ratification of KPMG as auditor for 2026 approved (42,760,080 for, 1,514,886 against).

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-26-019172
form_type: 8-K
ticker: NXDT
cik: 0001356115
company_name: NEXPOINT DIVERSIFIED REAL ESTATE TRUST
filed_at: 2026-06-02T20:26:15+00:00
discovered_at: 2026-06-02T20:27:00.200174+00:00
generated_at: 2026-06-02T20:27:08.467716+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-26-019172
json_url: https://secwatch.observer/filing/0001437749-26-019172.json
markdown_url: https://secwatch.observer/filing/0001437749-26-019172.md
text_url: https://secwatch.observer/filing/0001437749-26-019172.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1356115/000143774926019172/0001437749-26-019172-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1356115/000143774926019172/nexsof20260602_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

STTK

Shattuck Labs shareholders approve equity plan amendment adding 1.69M shares, extend term to 2036

Shattuck Labs, Inc. June 2, 2026, 5:00 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MAT

Mattel shareholders approve 2.155M share increase and extension of equity compensation plan to 2036

MATTEL INC /DE/ June 2, 2026, 4:47 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Orgenesis Inc.

Orgenesis shareholders approve 10x increase in authorized shares to 150M and convertible loan deal

Orgenesis Inc. June 2, 2026, 5:26 PM ET other_material Items 5.03, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

VRNS

Varonis stockholders approve 6.4M share increase in 2023 equity plan at annual meeting

VARONIS SYSTEMS INC June 2, 2026, 5:00 PM ET other_material Items 5.02, 5.07

same SEC item: 5.02, 5.07 same event type: other_material similar materiality

Filing page SEC filing

SNBR

Sleep Number grants $5.5M in one-time retention awards to five NEOs; CEO gets net $1.875M after waiver

Sleep Number Corp June 2, 2026, 4:05 PM ET other_material Items 5.02, 9.01

same SEC item: 5.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRCC

BRCC regains NYSE minimum share price compliance; reverse split approved but not needed

BRC Inc. June 2, 2026, 6:18 AM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NRXP

NRx Pharmaceuticals proposes public offering of common stock; terms not set

NRX Pharmaceuticals, Inc. June 2, 2026, 5:30 PM ET other_material Items 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001437749-26-019172

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.